Glenmark Pharmaceuticals
GLENMARK.NS
#2590
Rank
C$7.75 B
Marketcap
$27.49
Share price
0.55%
Change (1 day)
111.34%
Change (1 year)

Glenmark Pharmaceuticals (GLENMARK.NS) - Total debt

Total debt on the balance sheet as of March 2024 : C$0.20 Billion

According to Glenmark Pharmaceuticals 's latest financial reports the company's total debt is C$0.20 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Glenmark Pharmaceuticals - Total debt on balance sheet (from 2012 to 2024)

Total debt by year

Year Total debt Change
2023-03-31C$0.76 B16.85%
2022-03-31C$0.65 B-23.87%
2021-03-31C$0.85 B-12.15%
2020-03-31C$0.97 B14.03%
2019-03-31C$0.85 B-7.03%
2018-03-31C$0.91 B-5.36%
2017-03-31C$0.97 B24.66%
2016-03-31C$0.77 B1.22%
2015-03-31C$0.77 B27.7%
2014-03-31C$0.60 B16.42%
2013-03-31C$0.51 B17.55%
2012-03-31C$0.44 B-4%
2011-03-31C$0.45 B8.35%
2010-03-31C$0.42 B-18.57%
2009-03-31C$0.52 B104.33%
2008-03-31C$0.25 B1.42%
2007-03-31C$0.25 B30.26%
2006-03-31C$0.19 B58.89%
2005-03-31C$0.12 B249.53%
2004-03-31C$34.71 M